These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterisation of the spectrum of demyelinating disease in Western Australia. Wu JS, Zhang MN, Carroll WM, Kermode AG. J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258 [Abstract] [Full Text] [Related]
4. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study. Papais-Alvarenga RM, Vasconcelos CC, Carra A, de Castillo IS, Florentin S, Diaz de Bedoya FH, Mandler R, de Siervi LC, Pimentel ML, Alvarenga MP, Alvarenga MP, Grzesiuk AK, Gama Pereira AB, Gomes Neto AP, Velasquez C, Soublette C, Fleitas CV, Diniz DS, Armas E, Batista E, Hernandez F, Pereira FF, Siqueira HH, Cabeça H, Sanchez J, Brooks JB, Gonçalves MV, Barroso MC, Ravelo ME, Castillo MC, Ferreira ML, Rocha MS, Parolin MK, Molina O, Marinho PB, Christo PP, Brant de Souza R, Pessanha Neto S, Camargo SM, Machado SC, Neri VC, Fragoso YD, Alvarenga H, Thuler LC. PLoS One; 2015 Sep; 10(7):e0127757. PubMed ID: 26222205 [Abstract] [Full Text] [Related]
5. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica]. Bi CF, Qian HR, Peng LJ, Mao LL, Huang X, Xia DY, Lei X, Qi XK. Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609 [Abstract] [Full Text] [Related]
6. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J. Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988 [Abstract] [Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS). J Neuroinflammation; 2016 Sep 27; 13(1):280. PubMed ID: 27793206 [Abstract] [Full Text] [Related]
8. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge AE, Gurvit H, Saruhan-Direskeneli G, Yazici H, Eraksoy M. J Neurol; 2006 Jul 27; 253(7):928-34. PubMed ID: 16511642 [Abstract] [Full Text] [Related]
9. Clinical studies of multiple sclerosis in Japan. I. A current appraisal of 83 cases. Kuroiwa Y, Shibasaki H. Neurology; 1973 Jun 27; 23(6):609-17. PubMed ID: 4736306 [No Abstract] [Full Text] [Related]
10. Tumefactive multiple sclerosis in Taiwan. Kuan YC, Wang KC, Yuan WH, Tsai CP. PLoS One; 2013 Jun 27; 8(7):e69919. PubMed ID: 23875010 [Abstract] [Full Text] [Related]
11. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. Warabi Y, Matsumoto Y, Hayashi H. J Neurol Sci; 2007 Jan 15; 252(1):57-61. PubMed ID: 17125797 [Abstract] [Full Text] [Related]
12. Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Shibasaki H, Kuroiwa Y. Neurology; 1973 Jun 15; 23(6):618-22. PubMed ID: 4736307 [No Abstract] [Full Text] [Related]
13. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system]. Yang Y, Wu WP, Huang DH, Wu L. Zhonghua Yi Xue Za Zhi; 2012 Nov 20; 92(43):3032-5. PubMed ID: 23328372 [Abstract] [Full Text] [Related]
14. Multiple sclerosis--Indian experience. Singhal BS. Ann Acad Med Singap; 1985 Jan 20; 14(1):32-6. PubMed ID: 4004124 [Abstract] [Full Text] [Related]
15. [Late onset multiple sclerosis]. Delalande S, De Seze J, Ferriby D, Stojkovic T, Vermersch P. Rev Neurol (Paris); 2002 Nov 20; 158(11):1082-7. PubMed ID: 12451340 [Abstract] [Full Text] [Related]
16. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G, Italian Devic's Study Group (IDESG). J Neurol; 2004 Jan 20; 251(1):47-52. PubMed ID: 14999489 [Abstract] [Full Text] [Related]
17. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course. Bonek R, Orlicka K, Maciejek Z. Neurol Neurochir Pol; 2007 Jan 20; 41(3):229-33. PubMed ID: 17629816 [Abstract] [Full Text] [Related]
18. Profile of multiple sclerosis in the bombay region. On the basis of critical clinical appraisal. Singhal BS, Wadia NH. J Neurol Sci; 1975 Oct 20; 26(2):259-70. PubMed ID: 1176993 [Abstract] [Full Text] [Related]
19. Multiple sclerosis: Indian experience in the last thirty years. Jain S, Maheshwari MC. Neuroepidemiology; 1985 Oct 20; 4(2):96-107. PubMed ID: 3913869 [Abstract] [Full Text] [Related]
20. Comprehensive viral immunology of multiple sclerosis. I. Clinical, epidemiological, and CSF studies. Johnson KP, Likosky WH, Nelson BJ, Fein G. Arch Neurol; 1980 Sep 20; 37(9):537-41. PubMed ID: 7417053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]